CRG L.P.

Total investments

59

Average round size

52M

Portfolio companies

50

Rounds per year

2.81

Lead investments

12

Follow on index

0.15

Exits

33

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsHospitalGeneticsManufacturingMedical DeviceMedicalPharmaceuticalBiopharma

Summary

In 2003 was created CRG L.P., which is appeared as VC. The company was established in North America in United States. The leading representative office of defined VC is situated in the Houston.

The overall number of key employees were 7.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the CRG L.P., startups are often financed by New Enterprise Associates, MPM Capital, Delphi Ventures. The meaningful sponsors for the fund in investment in the same round are Warburg Pincus, The Vertical Group, Windham Venture Partners. In the next rounds fund is usually obtained by Warburg Pincus, T. Rowe Price, Perceptive Advisors.

Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2017. Opposing the other organizations, this CRG L.P. works on 18 percentage points more the average amount of lead investments.

Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight ViewRay, EndoGastric Solutions, Harmony Biosciences. We can highlight the next thriving fund investment areas, such as Life Science, Health Diagnostics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Show more

Investments analytics

Analytics

Total investments
59
Lead investments
12
Exits
33
Rounds per year
2.81
Follow on index
0.15
Investments by industry
  • Health Care (51)
  • Biotechnology (33)
  • Medical (26)
  • Medical Device (24)
  • Health Diagnostics (16)
  • Show 22 more
Investments by region
  • United States (52)
  • Canada (4)
  • Ireland (2)
  • New Zealand (1)
Peak activity year
2015
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
19
Avg. valuation at time of investment
48M
Group Appearance index
0.17
Avg. company exit year
16
Avg. multiplicator
0.96
Strategy success index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Calyxo 06 Jul 2022 Health Care, Wellness, Medical Device, Medical Late Stage Venture 32M United States, California, Pleasanton
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.